关于莱维拉塞坦诱导的低血清症的现实世界证据:一个活跃的比较者队列研究
Ohoud Almadani1, Raseel Alroba1, Almaha Alfakhri1
1Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Drugs - real world outcomes
|June 3, 2024
概括
这项研究表明, levetiracetam (一种抗发作药物) 可能与低血 (低) 的风险增加有关. 需要进一步的研究来证实这种潜在的安全信号.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 现实世界的证据研究研究.
背景情况:
- 列维是一种广泛使用的抗发作药物 (ASM).
- 之前曾报道过与使用 levetiracetam 相关的低血 (低水平) 的潜在安全问题.
- 这项研究旨在调查这种潜在的关联.
研究的目的:
- 确定使用 levetiracetam 和低血的发展之间是否存在因果关系.
- 为了比较开始服用 levetiracetam 和 carbamazepine 的患者的低血风险.
主要方法:
- 一项回顾性队列研究使用了2016-2022年的真实世界数据进行.
- 成年患者新处方的 levetiracetam 或 carbamazepine 被随访长达六个月.
- 低血症通过诊断码或低血清水平来确定;用于分析的是可克斯比例危险模型,该模型具有治疗权重的稳定反向概率.
主要成果:
- 这项研究包括8,982名患者.
- 低血的发病率在 levetiracetam 组 (303 个每 10,000 个患者年) 比卡巴马西平组 (57 个每 10,000 个患者年) 高.
- 与卡巴马西平使用者相比,使用 levetiracetam 用户的低血调整后危险比为1.99 (95% CI,0.88-4.49),敏感性分析的结果一致.
结论:
- 虽然危险比率在统计上是可比的,但观察到的高危险比率表明 levetiracetam 和低血之间存在潜在的关联.
- 不能最终排除 levetiracetam 和低血之间的关联.
- 需要进一步的研究来准确评估这种潜在的安全信号.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
512
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
512
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
01:20Antiepileptic Drugs: Potassium Channel Activators
171
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
171